Bio-Techne
TECH
#1558
Rank
$10.91 B
Marketcap
$68.72
Share price
3.54%
Change (1 day)
8.07%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Earnings for Bio-Techne (TECH)

Earnings in 2024 (TTM): $0.20 Billion USD

According to Bio-Techne's latest financial reports the company's current earnings are $1.15 Billion USD. In 2023 the company made an earning of $0.26 Billion USD a decrease over its 2022 earnings that were of $0.32 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bio-Techne from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.20 B-24.2%
2023 $0.26 B-19.25%
2022 $0.32 B50.77%
2021 $0.21 B-1.3%
2020 $0.22 B-15.46%
2019 $0.26 B82.56%
2018 $0.14 B11.13%
2017 $0.12 B1.19%
2016 $0.12 B-12.64%
2015 $0.14 B-9.33%
2014 $0.16 B2.19%
2013 $0.15 B-1.7%
2012 $0.16 B-3.5%
2011 $0.16 B6.2%
2010 $0.15 B-0.59%
2009 $0.15 B2.78%
2008 $0.15 B14.95%
2007 $0.13 B15.14%
2006 $0.11 B11.66%
2005 $0.10 B17.05%
2004 $88.43 M18.06%
2003 $74.9 M26.06%
2002 $59.41 M22.66%
2001 $48.44 M9.92%
2000 $44.06 M43.92%
1999 $30.62 M31.99%
1998 $23.2 M29.61%
1997 $17.9 M31.62%
1996 $13.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$6.85 B 3,305.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.01 Billion-599.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.67 B 730.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.08 B 1,927.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.14 B-28.40%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$8.28 B 4,014.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.82 Million-104.87%๐Ÿ‡บ๐Ÿ‡ธ USA